Relapses of vivax malaria after a conventional course of primaquine and chloroquine: report of 2 cases.
D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage; D002738:Chloroquine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D011319:Primaquine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D011803:Quinine / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors
D000962:Antimalarials; D002738:Chloroquine; D011803:Quinine; D005954:Glucosephosphate Dehydrogenase; D011319:Primaquine